Researchers have identified 63 proteins that act as high-confidence regulators of alternative polyadenylation (APA), a critical process in how cells express genetic information. Led by Gene Yeo of UC San Diego and Yongsheng Shi of UC Irvine, the study, published June 26, 2026, in Molecular Cell, used a large-scale screen of 879 RNA-binding proteins to map how specific proteins influence gene activity. This discovery provides a new framework for manipulating RNA processing, potentially enabling future gene-targeted therapies.
How do newly identified proteins control gene expression?
Most proteins identified in the study were previously unknown to influence APA, the mechanism that determines the length and stability of messenger RNA (mRNA). According to the study, only seven of the 63 identified activators had been linked to APA in prior research. By screening hundreds of RNA-binding proteins, the team found that proteins like GRB2 and RNPS1 play direct roles in interacting with cellular machinery to select poly(A) sites. This selection process is essential because it dictates which proteins a cell produces, effectively acting as a biological switch for gene function.
Alternative polyadenylation (APA) is a fundamental process that allows a single gene to produce multiple versions of an mRNA molecule. By changing the “end” of the RNA, cells can alter protein function or how long a protein lasts in the body.
Can artificial intelligence predict RNA regulatory functions?
The research team successfully trained a protein language model to predict which sequences within a protein are likely to regulate APA. By analyzing protein sequences, the model identified functional regions that drive RNA processing. According to the study authors, this approach significantly accelerates the discovery process compared to traditional lab-based screening. By automating the identification of these regulators, scientists can prioritize which proteins to study for therapeutic potential without testing every candidate manually.
What is the future of programmable RNA-targeting?
Beyond mapping these regulators, the study developed a programmable platform capable of recruiting specific proteins to targeted poly(A) sites. This tool allows researchers to artificially influence RNA processing within cells. By directing proteins to specific locations on an RNA strand, scientists can potentially “correct” faulty gene expression patterns. This technology offers a roadmap for future medical interventions where researchers might manually tune how genes are expressed to treat diseases caused by RNA processing errors.
Frequently Asked Questions
What is the primary significance of the 63 identified proteins?
These proteins act as “activators” that help the cell select specific poly(A) sites, a key step in determining how genes are expressed. Most were previously unknown to have this function, expanding the known toolkit for RNA regulation.
How does the protein language model work?
The model analyzes the sequence of amino acids in a protein to predict its regulatory role. It highlights specific structural regions that are critical for interacting with the cell’s RNA-processing machinery.
What are the potential clinical applications?
The development of a programmable RNA-targeting platform means scientists could one day design therapies that recruit specific regulators to fix misregulated genes, addressing diseases linked to RNA processing defects.
Keep an eye on advancements in “programmable RNA-targeting.” As these tools evolve, they will likely become a cornerstone in personalized medicine for genetic disorders.
Have questions about how RNA regulation impacts human health? Subscribe to our weekly newsletter for the latest updates on genetic research and biotechnology breakthroughs.
